Filter Holdings, Inc. is a leading provider of bag filters for construction (asphalt, cement), life science / pharma (oral solid dose), and liquid solid separation applications. Our high flex US-based facility helps filter users, OEMs, and distributors access best in class filtration. FHI ships crucial filtration components to customers around the world every day.

Within H&V Process Liquids included:- Water treatment: Municipal, California Title 22, Direct-to-Potable, Water re-use, CCL, waterborne illness, Industrial Re-Use, Point of Use (PoU), Point of Entry (PoE), Carbon, PFAS, PFOA, EPA, LCR- Bioprocess: Biopharmaceuticals, Large Molecule, Monoclonal Antibodies (mAbs), Biosimilars, Protein, Microbiome, Bacteria, Virus, Microbiology, Yeasts, 21CFR, Membranes, Ultrafiltration- Food and beverage: Beer, Wine, Point-of-Use Water, Dairy- Industrial chemicals: Semiconductor, Electronics, Dyes, Colorants, Metals, Mining, SeparationsH&V materials enable bioprocess, food, beverage, and water treatment processes around the world. Customer quality, compliance and regulatory expectations are met using quality management systems such as: HACCP, ISO 22000, ISO 13485.2022 - 2024: General Manager, Trupor and Microfiltration2020 - 2022: Global Marketing Director, Process Liquid 2020: N95 & Medical PPE Task Force 2017 - 2020: Director of Business Development - Includes Segment Lead, Liquid Filtration in Specialty Filtration Division

Cutting edge equipment maker crucial to improved performance in membrane, biopharma, water, battery, healthcare, and aerospace supply chains. Our technology drove better microbial management (bacteria, virus, protein, etc.), and higher performance in PPE, facemasks, and other medical barriers (NIOSH, N95, FDA, and surgical). Headquarters and plant in Czech Republic, lab and office in NC, USA.2016 – 2017: Consultant.2015 – 2016: CEO. (Full P&L responsibility, global team of 50.)2013 – 2015: VP, Global Sales.2008 – 2013: VP, US Sales; promoted to President, US Operations.

Parish invested $2 Bn in nearly 100 VC and buyout funds from around the world. Diligence and investments in many VC and buyout funds early in their life - Emergence Capital, Alsop Louie, Altos, DW Healthcare Partners, Linden Life Science, Milestone - Parish invested in many other well known VCs. StepStone acquired Parish in 2012. Parish's emerging illiquid investment strategy identified and invested in high growth funds focused on SaaS, biopharma, medical device, data science, manufacturing and other areas. 2007 - 2008: Vice President2005 - 2006: Investment Manager2003 - 2004: MBA Intern

Unitive's chip packaging made graphics cards faster, sensors smaller, and enabled the supply chain conversion to smart phones. Processing was done at two wafer fabs - the initial plant was in Durham, NC and the second in Hsinchu, Taiwan. Amkor Technologies (AMKR) bought Unitive in 2004. Investors included Onex Corp., TransAtlantic Technology, Fairchild Semiconductor, Conexant, Flextronics and Celestica.

* Promoted from analyst.* Aided in structuring funding of strategic growth for privately held businesses; including family-owned businesses dealing with succession; ESOPs and ESOP plans; and sourcing of private equity and debt.